Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A. Vitanza, Julie R. Park, Adam Johnson et al.|Nature Medicine|2021Cited by 319
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and SafetyNicholas A. Vitanza, Julie R. Park, Kristy Seidel et al.|Cancer Discovery|2022Cited by 277
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A. Vitanza, Michael C. Jensen, Rebecca Ronsley et al.|Nature Medicine|2025Cited by 154
Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trialJuliane Gust, Julie R. Park, Bonnie Cole et al.|Neuro-Oncology|2025Cited by 16
Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell MalignanciesJennifer L. McGuire, Juliane Gust, Soniya Pinto et al.|Neurology|2025Cited by 8